Azerbaijan vs Central African Republic: Immunization, Hib3
Immunization, Hib3 over time
- Azerbaijan
- Central African Republic
How they compare
Azerbaijan currently reports 51.0% against 42.0% in Central African Republic, a difference of 9.0%.
That makes Azerbaijan's figure about 1.2 times Central African Republic's.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Central African Republic ahead.
Azerbaijan ranks 186th and Central African Republic ranks 188th of 191 countries.
Azerbaijan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Central African Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.9% | 40.8% | 37.1% | Azerbaijan |
| 2020s | 51.6% | 37.4% | 14.2% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Azerbaijan or Central African Republic?
- Azerbaijan, at 51.0% against 42.0% in Central African Republic as of 2024.
- What is the difference in immunization, hib3 between Azerbaijan and Central African Republic?
- 9.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Central African Republic?
- 14 years are reported by both, from 2011 to 2024.
- How do Azerbaijan and Central African Republic rank globally for immunization, hib3?
- Azerbaijan ranks 186th and Central African Republic ranks 188th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.